Deckelbaum, Richard J. and Calder, Philip (2020) Is it time to separate EPA from DHA when using omega-3 fatty acids to protect heart and brain? Current Opinion in Clinical Nutrition and Metabolic Care, 23 (2), 65-67. (doi:10.1097/MCO.0000000000000632).
Record type:
Editorial
Text
COCN editorial Deckelbaum and Calder Dec 13 2019
- Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (127kB)
More information
Accepted/In Press date: 20 December 2019
Published date: 1 March 2020
Additional Information:
Funding Information:
R.J.D is a founding scientist and member of the scientific advisory board of DeckTherapeutics, Inc., a company developing diglyceride lipid emulsions to prevent tissue death after ischemic organ injuries. R.J.D is an inventor on Columbia University assigned patents on omega-3 rich diglyceride emulsions as potential agents for cyto-protection of different organs after ischemic injury. P.C.C. acts as a consultant to Cargill, DSM and Smart-fish and has research funding from BASF AS.
Identifiers
Local EPrints ID: 438019
URI: http://eprints.soton.ac.uk/id/eprint/438019
ISSN: 1363-1950
PURE UUID: 1322ea27-1fb9-48d6-ad3d-3266293b3b6e
Catalogue record
Date deposited: 26 Feb 2020 17:31
Last modified: 17 Mar 2024 05:21
Export record
Altmetrics
Contributors
Author:
Richard J. Deckelbaum
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.